VIMIAN Vimian Group AB (publ)

STO · SE · Healthcare · Diagnostics & Research · vimian.com

35.40SEK+0.57%Mkt Cap: 1.78B $P/E: 44.56Today

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers proprietary diagnostics, pres…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc Common Stock

$242.11BUSDP/E 35.5

DHR

Danaher Corporation Common Stock

$150.48BUSDP/E 38.2

NTRA

Natera, Inc. - Common Stock

Agilent Technologies, Inc. Common Stock

$47.30BUSDP/E 33.1

IQV

IQVIA Holdings, Inc. Common Stock

$42.50BUSDP/E 32.2

WAT

Waters Corporation Common Stock

$41.75BUSDP/E 107.4

ILMN

Illumina, Inc. - Common Stock

$41.23BUSDP/E 50.8

IDXX

IDEXX Laboratories, Inc. - Common Stock

$40.89BUSDP/E 36.4

MTD

Mettler-Toledo International, Inc. Common Stock

$29.78BUSDP/E 34.0

DGX

Quest Diagnostics Incorporated Common Stock

$25.75BUSDP/E 25.0

Labcorp Holdings Inc. Common Stock

$25.02BUSDP/E 25.5

Guardant Health, Inc. - Common Stock

$23.86BUSD

RVTY

Revvity, Inc. Common Stock

$16.91BUSDP/E 72.5

MEDP

Medpace Holdings, Inc. - Common Stock

$16.73BUSDP/E 35.2

ERF

Eurofins Scientific SE

$13.92BUSDP/E 26.0

CRL

Charles River Laboratories International, Inc. Common Stock

$13.85BUSD

ICLR

ICON plc - Ordinary Shares

Qiagen N.V. Common Shares

$9.24BUSDP/E 22.7

Key Statistics

Company

Market Cap1.78B USD

Enterprise Value24.52M USD

Revenue (TTM)43.13M USD

Gross Profit28.01M USD

Net Income (TTM)2.99M USD

Revenue/Share0.85 SEK

Last Price35.40 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1.3K

CountrySE

SectorHealthcare

IndustryDiagnostics & Research

ISINSE0015961982

Valuation

P/E (Trailing)44.56

P/E (Forward)26.47

PEG—

EV/EBITDA2.25

EV/Revenue0.57

P/S41.23

P/B25.79

EPS (TTM)0.66

EPS (Forward)1.33

52W Range

24.1891% of range36.45

52W High36.45 SEK

52W Low24.18 SEK

Profitability

Gross Margin68.89%

Oper. Margin18.42%

EBITDA Margin25.33%

Profit Margin7.36%

ROE4.48%

ROA2.82%

Growth

Revenue Growth16.60%

Earnings Growth0.20%

Cash Flow & Leverage

Operating CF10.11M USD

CapEx (TTM)1.44M USD

FCF Margin8.37%

FCF Yield0.20%

Net Debt21.73M USD

Net Debt/EBITDA1.99

Balance Sheet

Debt/Equity0.34

Current Ratio2.43

Quick Ratio1.35

Book Value/Sh1.36 SEK

Cash/Share97.29 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.2 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)37.04 SEK

Upside (mean)+4.6%

Target Range29.46 SEK – 41.86 SEK

29.46+4.6% to mean41.86

# Analysts6

Ownership

Shares Out.527.14M

Float186.18K

Insiders5.44%

Institutions85.96%

Technical

SMA 5035.02 (+1.1%)

SMA 20030.46 (+16.2%)

Beta1.19

S&P 52W Chg14.58%

Avg Vol (30d)627.42K

Avg Vol (10d)245.24K

Technical Indicators

RSI (14)50.7

MACD0.2979

MACD Signal0.3073

MACD Hist.-0.0094

BB Upper36.51 SEK

BB Middle35.09 SEK

BB Lower33.66 SEK

BB Width8.13%

ATR (14)0.8892 SEK

Vol Ratio (20d)0.34x